We are live on ! Find out more
IRD

Opus Genetics

35 hedge funds and large institutions have $5.32M invested in Opus Genetics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

0% more funds holding

Funds holding: 3535 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

11% less capital invested

Capital invested by funds: $5.94M → $5.32M (-$626K)

Holders
35
Holders Change
Holders Change %
0%
% of All Funds
0.94%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
7
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change

IRD Hedge Fund Activity: Q2 2015 in Review

35 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2015, worth a combined $5.32M — down 11% from $5.94M a quarter earlier.

Fund positioning in IRD was balanced in Q2 2015: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $202K. The largest seller was AQR Capital Management, cutting an estimated $73.7K.

  • 35 institutional investors held Opus Genetics (IRD) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $5.32M of Opus Genetics stock for Q2 2015, down 11% quarter-over-quarter.
  • 5 funds opened new Opus Genetics positions in Q2 2015 and 5 closed out, a net change of 0 holders.
  • The largest Opus Genetics buyer in Q2 2015 was Renaissance Technologies, an estimated $202K added.
  • The largest Opus Genetics seller in Q2 2015 was AQR Capital Management, an estimated $73.7K sold.

Based on aggregated 13F filings for Q2 2015.